ConductScience.org, home

Paper57788

The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.

Twentyman PR and 1 other. Br J Cancer, 1976. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Papers, record 57788. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57788

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
PubMed
Journal
Br J Cancer
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Twentyman PRP R
2Bleehen NMN M

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Lung NeoplasmsMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Bleomycin
Carmustine
Cell Line
Cell Survival
Cyclophosphamide
Dose-Response Relationship, Drug
Doxorubicin
Lomustine
Male
Mice
Mice, Inbred BALB C
Time Factors

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11120304The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.Cancer Res1975https://conductscience.org/library/papers/1120304PubMed
21131813In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.Cancer Res1975https://conductscience.org/library/papers/1131813PubMed
31156523Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.Br J Cancer1975https://conductscience.org/library/papers/1156523PubMed
41169108Stem-cell survival and tumor control in the Lewis lung carcinoma.Cancer Res1975https://conductscience.org/library/papers/1169108PubMed
54125097The sensitivity to bleomycin of spleen colony forming units in the mouse.Br J Cancer1973https://conductscience.org/library/papers/4125097PubMed
64126375Response of a murine solid tumor to in vivo combined chemotherapy and irradiation.Radiology1973https://conductscience.org/library/papers/4126375PubMed
74128424Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.Cancer Chemother Rep1973https://conductscience.org/library/papers/4128424PubMed
84135685Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin.Cancer Res1974https://conductscience.org/library/papers/4135685PubMed
94143273The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.Br J Cancer1974https://conductscience.org/library/papers/4143273PubMed
104578656Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.Cancer Res1973https://conductscience.org/library/papers/4578656PubMed
114607700Are cell kinetic data relevant for the design of tumour chemotherapy schedules?Cell Tissue Kinet1974https://conductscience.org/library/papers/4607700PubMed
124633910Tumor chemotherapy: efficacy dependent on mode of growth.J Natl Cancer Inst1973https://conductscience.org/library/papers/4633910PubMed
134646827Cell proliferation and the action of cytotoxic agents on haemopoietic tissue.Br J Haematol1972https://conductscience.org/library/papers/4646827PubMed
144647494Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.J Natl Cancer Inst1972https://conductscience.org/library/papers/4647494PubMed
154678087Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.Curr Top Radiat Res Q1972https://conductscience.org/library/papers/4678087PubMed
1647265Studies on recovery from chemically induced damage in mammalian cells.Cancer Res1975https://conductscience.org/library/papers/47265PubMed
1748253Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/48253PubMed
184858112Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.Cancer Res1974https://conductscience.org/library/papers/4858112PubMed
1955271Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.Br J Cancer1975https://conductscience.org/library/papers/55271PubMed
205799415The influence of the anatomic locationof a tumor on its susceptibility to chemotherapy.Cancer Chemother Rep1969https://conductscience.org/library/papers/5799415PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
23536304Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23536304PubMed
7073936In vivo tumour-cell proliferation after adriamycin treatment.Br J Cancer1982https://conductscience.org/library/papers/7073936PubMed
6691899A bioassay for cyclophosphamide in blood, lung and tumour.Br J Cancer1984https://conductscience.org/library/papers/6691899PubMed
911660Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation.Br J Cancer1977https://conductscience.org/library/papers/911660PubMed
889677Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.Br J Cancer1977https://conductscience.org/library/papers/889677PubMed
836758Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.Br J Cancer1977https://conductscience.org/library/papers/836758PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/57788

GET https://conductscience.org/api/papers/v1/57788/authors